Page last updated: 2024-11-06
2-diazofluorene
Description
2-diazofluorene is a diazo compound with the molecular formula C13H8N2. It is a yellow solid that is sensitive to light and heat. 2-diazofluorene is a versatile synthetic reagent used in organic chemistry, particularly in the synthesis of complex molecules. It is a valuable precursor to various heterocyclic compounds, including pyrazoles and triazoles, through reactions such as cycloaddition and electrophilic aromatic substitution. Its importance in organic synthesis stems from its ability to act as a carbene precursor, generating highly reactive intermediates that can participate in a range of organic transformations. 2-diazofluorene is also studied for its potential applications in materials science, particularly in the development of organic light-emitting diodes (OLEDs) and photovoltaics. Research efforts focus on understanding its photophysical properties and exploring its suitability as a building block for functional materials. 2-diazofluorene is a highly reactive compound, and its handling requires caution due to its potential for explosion. Proper safety measures should be taken when working with this compound.'
2-diazofluorene: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 70028 |
CHEMBL ID | 386841 |
SCHEMBL ID | 482108 |
MeSH ID | M0149689 |
Synonyms (19)
Synonym |
nsc167093 |
9h-fluorene, 9-diazo- |
9-diazofluorene |
nsc-167093 |
fluorene, 9-diazo- |
832-80-4 |
2-diazofluorene |
CHEMBL386841 |
9-diazo-fluorene |
fluorene, 9-diazo- (van) |
8be76eab5e , |
unii-8be76eab5e |
nsc 167093 |
FT-0621644 |
AKOS015900580 |
DTXSID50232218 |
SCHEMBL482108 |
9-diazo-9h-fluorene |
diazofluorene |
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (9.09) | 18.7374 |
1990's | 6 (54.55) | 18.2507 |
2000's | 4 (36.36) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (9.09%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (90.91%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |